Literature DB >> 11166975

Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice.

J M Laird1, C Roza, C De Felipe, S P Hunt, F Cervero.   

Abstract

Substance P and its receptor (NK1) are thought to play an important role in pain and hyperalgesia. Here we have further examined this role by comparing the behavioural responses to intradermal capsaicin of mutant mice with a disruption of the NK1 receptor (NK1 KO) and wild-type (WT) mice. We have also evaluated the contribution of peripheral NK1 receptors to capsaicin-evoked behaviour by selective blockade of peripheral NK1 receptors in WT mice using a non-brain penetrant NK1 receptor antagonist. Injection of 6 microg capsaicin into the heel evoked paw licking with the same latency in WT and KO mice, but a significantly longer duration in WT mice. A higher dose (30 microg) evoked a similar duration of licking in both groups. There were no differences in mechanical sensitivity tested with von Frey hairs between WT and KO mice before capsaicin. Both capsaicin doses resulted in pronounced increases in responses to von Frey hairs (hyperalgesia) and novel responses to cotton wisps (allodynia) applied to the digits of the injected paw in WT mice, but no significant changes from baseline in KO mice. Selective blockade of peripheral NK1 receptors in WT mice resulted in a complete inhibition of capsaicin-evoked plasma extravasation, but the mechanical hyperalgesia induced by 30 microg capsaicin intraplantar was still significantly greater than that seen in KO mice. We conclude that the response to intradermal capsaicin is still present but abbreviated in mice lacking NK1 receptors, such that secondary hyperalgesia is not observed even after a high dose. Further, the lack of secondary hyperalgesia in NK1 KO mice is largely due to the loss of central rather than peripheral NK1 receptors. The phenotype of the NK1 KO mice is consistent with a loss of function of mechanically-insensitive nociceptors, and thus we propose that substance P may be expressed by this group of primary sensory neurones and required for their function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166975     DOI: 10.1016/s0304-3959(00)00394-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  13 in total

1.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

Review 2.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 3.  TRPV1 and SP: key elements for sepsis outcome?

Authors:  Jennifer Victoria Bodkin; Elizabeth Soares Fernandes
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat.

Authors:  M Gautam; P Prasoon; R Kumar; K H Reeta; S Kaler; S B Ray
Journal:  Spinal Cord       Date:  2015-12-22       Impact factor: 2.772

5.  Attenuation of thermal nociception and hyperalgesia by VR1 blockers.

Authors:  Carolina García-Martinez; Marc Humet; Rosa Planells-Cases; Ana Gomis; Marco Caprini; Felix Viana; Elvira De La Pena; Francisco Sanchez-Baeza; Teresa Carbonell; Carmen De Felipe; Enrique Pérez-Paya; Carlos Belmonte; Angel Messeguer; Antonio Ferrer-Montiel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  NMDA receptors in primary afferents require phosphorylation by Src family kinases to induce substance P release in the rat spinal cord.

Authors:  W Chen; G Zhang; J C G Marvizón
Journal:  Neuroscience       Date:  2010-01-13       Impact factor: 3.590

Review 7.  Visceral pain: the neurophysiological mechanism.

Authors:  Jyoti N Sengupta
Journal:  Handb Exp Pharmacol       Date:  2009

Review 8.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

9.  Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.

Authors:  Juan Carlos G Marvizon; Xueren Wang; Li-Jun Lao; Bingbing Song
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

Review 10.  Common and discrete mechanisms underlying chronic pain and itch: peripheral and central sensitization.

Authors:  Chengjin Li; Hee Jin Kim; Seung Keun Back; Heung Sik Na
Journal:  Pflugers Arch       Date:  2021-07-10       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.